2009
DOI: 10.1056/nejmoa0806414
|View full text |Cite
|
Sign up to set email alerts
|

Emergence of Ciprofloxacin-ResistantNeisseria meningitidisin North America

Abstract: We report on three cases of meningococcal disease caused by ciprofloxacin-resistant Neisseria meningitidis, one in North Dakota and two in Minnesota. The cases were caused by the same serogroup B strain. To assess local carriage of resistant N. meningitidis, we conducted a pharyngeal-carriage survey and isolated the resistant strain from one asymptomatic carrier. Sequencing of the gene encoding subunit A of DNA gyrase (gyrA) revealed a mutation associated with fluoroquinolone resistance and suggests that the r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

10
74
2
1

Year Published

2010
2010
2023
2023

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 124 publications
(90 citation statements)
references
References 25 publications
10
74
2
1
Order By: Relevance
“…Despite this limitation, the use of ceftriaxone as empirical therapy in our institution is recommended until penicillin susceptibility has been determined [25,26]. In our series, resistance to fluoroquinolones was not described; however, resistance to this antimicrobial group has been documented in recent publications in North America [10].…”
Section: Discussionmentioning
confidence: 95%
See 1 more Smart Citation
“…Despite this limitation, the use of ceftriaxone as empirical therapy in our institution is recommended until penicillin susceptibility has been determined [25,26]. In our series, resistance to fluoroquinolones was not described; however, resistance to this antimicrobial group has been documented in recent publications in North America [10].…”
Section: Discussionmentioning
confidence: 95%
“…A vaccine against serogroup B is not available, however, two possible candidates obtained from meningococcal recombinant proteins are under development. The emergence of N. meningitidis strains resistant to different antimicrobial agents has been recorded, with resistance to penicillin found in multiple countries [10] and resistance to quinolones reported in North America in recent years [11,12,13].…”
Section: Introductionmentioning
confidence: 99%
“…On the other hand, resistant N. meningitidis has not spread widely, possibly because the acquisition of rifampicin resistance appears to confer a biological disadvantage [71]. Ciprofloxacin-resistant N. meningitidis was isolated in the USA in 2009 from three IMD cases and two carriers, one after contact with one of the patients and after receipt of ciprofloxacin [78] ; no further cases have been described after recommendations to use other antibiotics for prophylaxis in the affected regions. Another theoretical negative effect of chemoprophylaxis is the eradication of N. lactamica from the nasopharynx.…”
Section: Discussionmentioning
confidence: 99%
“…Commensals are reservoirs of antibiotic resistance determinants, and HGT likely plays an important role in their spread among the pathogens. Supporting this notion are the observations that a N. meningitidis strain responsible for an outbreak in the Midwest appears to have acquired its ciprofloxacin-resistant gyrA allele from commensal N. lactamica carried in the community (27); and that the cephalosporin resistance of some N. gonorrhoeae strains is because of mosaic penA alleles of commensal origin (28)(29)(30).…”
Section: Discussionmentioning
confidence: 99%